HIV- 1 kliniske isolater, der er resistente over for nucleosid- analog reverse transcriptase- hæmmere (NRTI), non- nucleosid- analog reverse transcriptase- hæmmere (NNRTI), proteasehæmmere (PI) og enfuvirtid var alle følsomme over for maraviroc i cellekulturer.
HIV-1 clinical isolates resistant to nucleoside analogue reverse transcriptase inhibitors (NRTI), non- nucleoside analogue reverse transcriptase inhibitors (NNRTI), protease inhibitors (PI) and enfuvirtide